For more than a century, the Department of Pediatrics at Washington University School of Medicine has educated leading physicians and scientists and has been committed to excellence in patient care, basic and clinical research, and teaching. Indeed, Washington University School of Medicine and St. Louis Children's Hospital are consistently ranked among the best.
The Division of Pediatric Allergy and Pulmonary Medicine at St. Louis Children’s Hospital continues to flourish, supporting premier clinical and research programs in pulmonary and allergic diseases of children. The Division provides exceptional care for children with various allergic and pulmonary diseases, and pursues its academic mission to advance knowledge of the molecular and immunological basis of these conditions and develop novel diagnostic and treatment approaches to improve outcomes of these diseases. Its strong commitment to excellence in patient care, teaching, and investigation was recognized by the Division’s ranking as one of America’s best pulmonary services, according to CHILD Magazine’s 2007 survey.
In our Division you will find:
- active ACGME-accredited pediatric fellowship training programs in pediatric pulmonology and allergy-immunology,
- a center that is participating in three National Institutes of Health-funded childhood asthma research networks, including the Children’s Asthma Management Program (CAMP), Childhood Asthma Research and Education Network (CARE), and the Inner City Asthma Consortium (ICAC),
- a National Institutes of Health-sponsored, multidisciplinary center examining pulmonary complications leading to morbidity and mortality in sickle cell disease,
- a cystic fibrosis center that cares for more than 500 patients and actively participates in the Therapeutic Development Network, a Cystic Fibrosis Foundation-supported program designed to rapidly bring new therapies to cystic fibrosis patients,
- a pediatric lung transplantation program that cares for the largest cohort of lung and heart-lung transplant recipients in North America,
- a center for the Genetic Determinants of Mucociliary Clearance Consortium, part of the National Institutes of Health Rare Diseases Clinical Research Network, created to better define pathogenesis and treatment of primary ciliary dyskinesia and atypical forms of cystic fibrosis,
- a Sleep Medicine Center and fully automated Pediatric Sleep Diagnostics Laboratory,
- a multispecialty clinic for chronically ill children who are technology-dependent,
- a bronchoscopy center where more than 200 procedures are performed annually,
- a state-of-the-art pulmonary function laboratory proficient in performing both pediatric and infant studies, routinely serving more than 5000 patient visits each year, and
- renowned research programs that are examining the cellular and molecular mechanisms and disease processes of asthma, cystic fibrosis, primary ciliary dyskinesia, bronchiolitis obliterans, surfactant deficiencies, and respiratory infections.